Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acute Pancreatitis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The latest acute pancreatitis market research report reveals a projected growth to $7.41 billion by 2028, highlighting key factors such as increased alcohol consumption, the rising global obesity epidemic, the uptick in gastrointestinal disorders, and significant technological advancements in diagnosis and treatment methods.
As the incidence of health conditions such as obesity continues to climb worldwide, the acute pancreatitis market is expecting robust growth at a compound annual growth rate (CAGR) of 5.7%. This comprehensive market analysis scrutinizes the interplay of diverse driving forces shaping this market's expansion.
Alcohol Consumption Trends act as a significant propeller of the market, owing to the established link between ethanol-based beverage intake and pancreatitis. With staggering growth in online alcohol sales reported over recent years, this factor is expected to remain a pivotal market stimulant.
The Rise of Obesity Globally is identified as another formidable growth facilitator for the acute pancreatitis market. As obesity rates escalate across the globe, the demand for effective management of obesity-related health conditions, including acute pancreatitis, is intensifying.
Furthermore, the Increasing Prevalence of Gastrointestinal Disorders is poised to contribute significantly to the market's growth trajectory. With various GI disorders affecting an increasingly large patient population, there is a heightened demand for critical diagnostic and treatment services.
Technological advancements are at the forefront of emerging trends within the market. New developments in diagnostic imaging and treatment methodologies represent monumental strides forward. The introduction of advanced ultrasound systems and AI partnerships aimed at uncovering pioneering therapies illustrates the innovative pace of this sector.
Leading Technological Advancements
- Ultrasound Innovation: The launch of high-end ultrasound devices specialized for multiple medical disciplines is reshaping diagnostic practices.
- Artificial Intelligence: Collaborations integrating AI in the pursuit of groundbreaking therapies indicate a new frontier in acute pancreatitis treatment research.
The market report meticulously analyzes market statistics, offering an in-depth view of historical growth, current market conditions, and future forecasts. It lends insights into regional and global market sizes, shares, and segmentations, along with detailed evaluations of the key players and geographic regions driving the industry forward.
A selection of companies mentioned in this report includes
- CalciMedica Inc.
- SCM Lifescience Co. Ltd.
- Samsung Bioepis Co Ltd.
- Global Neurotech Pharma Corporation
- Baxter International Inc.
- B. Braun Melsungen AG
- General Electric Company
- Medtronic plc
- Boston Scientific Corporation
- Fresenius Kabi AG
- McNeil Consumer Healthcare
- Sun BioPharma Inc.
- Atox Bio Inc.
- D-Pharm Ltd.
- Regeneron Pharmaceuticals Inc.
- Merck & Co Inc
- Olympus Corporation
- Pfizer Inc.
- Ionis Pharmaceuticals Inc.
- Abbott Laboratories
- Dynavax Technologies Corporation
- GlaxoSmithKline plc
- AbbVie Inc.
- Allergan plc
- Amgen Inc.
- AstraZeneca PLC
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Novartis AG
- Sanofi SA
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Vertex Pharmaceuticals Incorporated
- Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/r/744kq9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
